Compare ZVRA & RSVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZVRA | RSVR |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 664.7M | 681.9M |
| IPO Year | 2015 | 2020 |
| Metric | ZVRA | RSVR |
|---|---|---|
| Price | $12.01 | $10.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $25.25 | $13.00 |
| AVG Volume (30 Days) | ★ 815.8K | 45.7K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 159.21 | 8.33 |
| EPS | ★ 1.03 | 0.07 |
| Revenue | $106,470,000.00 | ★ $175,664,491.00 |
| Revenue This Year | $43.42 | $8.25 |
| Revenue Next Year | $16.20 | $5.49 |
| P/E Ratio | ★ $11.25 | $145.71 |
| Revenue Growth | ★ 350.91 | 10.69 |
| 52 Week Low | $8.01 | $7.07 |
| 52 Week High | $15.04 | $13.39 |
| Indicator | ZVRA | RSVR |
|---|---|---|
| Relative Strength Index (RSI) | 63.37 | 70.40 |
| Support Level | $9.58 | $9.93 |
| Resistance Level | $12.19 | $11.22 |
| Average True Range (ATR) | 0.54 | 0.27 |
| MACD | 0.23 | 0.09 |
| Stochastic Oscillator | 93.43 | 61.47 |
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
Reservoir Media Inc is an independent music company. The company operates a music publishing business, a recorded music business, a management business, and a rights management entity in the Middle East. The company's segments include Music Publishing and Recorded Music. It generates the maximum of its revenue from the U.S. Music Publishing segment engaged in the acquisition of interests in music catalogs to earn royalties and signing songwriters to agreements of future delivery of songs. The Recorded Music segment involve the acquisition of sound recording catalogs and the discovery and development of recording artists and the marketing, distribution, sale and licensing of the music catalog.